Skip to main content

GERD & the physician-focused 3rd generation of Stretta: Q&A with Dr. Mark Noar

Stretta found to be effective in more GERD patient sub-sets: Q&A with Dr. Mark Noar on his follow-up to 10-year patient data.
Stretta, a non-ablative radiofrequency treatment for gastroesophageal reflux disease, is a safe and effective treatment. Numerous studies have confirmed this, including 10-year patient data released in 2014. Mederi Therapeutics launched RFT3, the third generation of Stretta technology, at Digestive Disease Week 2016 in San Diego.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2022 Esophageal Cancer Education Foundation- by domino